BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 22006378)

  • 1. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA; Ascher NL; Freise CE; Dodge JL; Roberts JP
    Liver Transpl; 2012 Feb; 18(2):160-5. PubMed ID: 22006378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
    Shen B; Chen B; Zhang W; Mao H; Shen C; Deng X; Zhan X; Chen H
    Liver Transpl; 2009 Nov; 15(11):1473-80. PubMed ID: 19877254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which score system can best predict recipient outcomes after living donor liver transplantation?
    Chung IS; Park M; Ko JS; Gwak MS; Kim GS; Lee SK
    Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and limitation of living donor liver transplantation for hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Wong J
    Liver Transpl; 2004 Mar; 10(3):440-7. PubMed ID: 15004774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does living donation have advantages over deceased donation in liver transplantation?
    Kaido T; Uemoto S
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of patients with hepatorenal syndrome after living donor liver transplantation.
    Lee JP; Kwon HY; Park JI; Yi NJ; Suh KS; Lee HW; Kim M; Oh YK; Lim CS; Kim YS
    Liver Transpl; 2012 Oct; 18(10):1237-44. PubMed ID: 22714872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
    Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.